AstraZeneca Gets in on ADC Therapeutics' Mega $200M Funding Round Post author:Sam Post published:October 22, 2017 Post category:BioPharma ADC Therapeutics announced it had raised $200M through an oversubscribed private placement. Source: BioSpace You Might Also Like Polyphor Announces Successful End Of Phase II Meeting With FDA For Murepavadin In Nosocomial Pneumonia May 18, 2017 Chattem, Inc.???s Xyzal Allergy 24HR Launches To OTC Market March 29, 2017 Scientists Use Graphene To Power 'Electronic Skin' That Can Feel, University of Glasgow Study Reveals March 22, 2017
Polyphor Announces Successful End Of Phase II Meeting With FDA For Murepavadin In Nosocomial Pneumonia May 18, 2017
Scientists Use Graphene To Power 'Electronic Skin' That Can Feel, University of Glasgow Study Reveals March 22, 2017